Annual EBIT
-$468.58 M
-$130.78 M-38.71%
31 December 2023
Summary:
Cytokinetics Incorporated annual earnings before interest & taxes is currently -$468.58 million, with the most recent change of -$130.78 million (-38.71%) on 31 December 2023. During the last 3 years, it has fallen by -$379.96 million (-428.78%). CYTK annual EBIT is now -1966.61% below its all-time high of $27.12 million.CYTK EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$138.25 M
-$19.23 M-16.16%
30 September 2024
Summary:
Cytokinetics Incorporated quarterly earnings before interest & taxes is currently -$138.25 million, with the most recent change of -$19.23 million (-16.16%) on 30 September 2024. Over the past year, it has dropped by -$22.82 million (-19.77%). CYTK quarterly EBIT is now -346.56% below its all-time high of $56.07 million, reached on 30 June 2009.CYTK Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$495.42 M
-$22.82 M-4.83%
30 September 2024
Summary:
Cytokinetics Incorporated TTM earnings before interest & taxes is currently -$495.42 million, with the most recent change of -$22.82 million (-4.83%) on 30 September 2024. Over the past year, it has dropped by -$25.57 million (-5.44%). CYTK TTM EBIT is now -1938.09% below its all-time high of $26.95 million, reached on 30 September 2009.CYTK TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTK EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -38.7% | -19.8% | -5.4% |
| 3 y3 years | -428.8% | -100.5% | -150.2% |
| 5 y5 years | -453.1% | -503.5% | -435.5% |
CYTK EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -428.8% | at low | -1281.1% | at low | -173.4% | at low |
| 5 y | 5 years | -453.1% | at low | -2307.7% | at low | -544.1% | at low |
| alltime | all time | -1966.6% | at low | -346.6% | at low | -1938.1% | at low |
Cytokinetics Incorporated EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$138.25 M(+16.2%) | -$495.42 M(+4.8%) |
| June 2024 | - | -$119.02 M(+0.6%) | -$472.60 M(+0.8%) |
| Mar 2024 | - | -$118.32 M(-1.3%) | -$468.85 M(+0.1%) |
| Dec 2023 | -$468.58 M(+38.7%) | -$119.83 M(+3.8%) | -$468.58 M(-0.3%) |
| Sept 2023 | - | -$115.43 M(+0.1%) | -$469.86 M(-2.3%) |
| June 2023 | - | -$115.27 M(-2.4%) | -$480.97 M(+28.0%) |
| Mar 2023 | - | -$118.05 M(-2.5%) | -$375.71 M(+11.2%) |
| Dec 2022 | -$337.80 M(+81.6%) | -$121.11 M(-4.3%) | -$337.80 M(+41.5%) |
| Sept 2022 | - | -$126.54 M(+1164.2%) | -$238.77 M(+31.8%) |
| June 2022 | - | -$10.01 M(-87.5%) | -$181.20 M(-19.8%) |
| Mar 2022 | - | -$80.14 M(+262.9%) | -$225.80 M(+21.4%) |
| Dec 2021 | -$185.98 M(+109.9%) | -$22.08 M(-68.0%) | -$185.98 M(-6.1%) |
| Sept 2021 | - | -$68.97 M(+26.3%) | -$197.98 M(+61.3%) |
| June 2021 | - | -$54.61 M(+35.4%) | -$122.75 M(+23.8%) |
| Mar 2021 | - | -$40.32 M(+18.3%) | -$99.11 M(+11.8%) |
| Dec 2020 | -$88.61 M(-6.1%) | -$34.08 M(-644.2%) | -$88.61 M(+15.2%) |
| Sept 2020 | - | $6.26 M(-120.2%) | -$76.91 M(-27.5%) |
| June 2020 | - | -$30.98 M(+3.9%) | -$106.08 M(+5.3%) |
| Mar 2020 | - | -$29.82 M(+33.3%) | -$100.78 M(+6.8%) |
| Dec 2019 | -$94.33 M(+11.3%) | -$22.38 M(-2.3%) | -$94.33 M(+2.0%) |
| Sept 2019 | - | -$22.91 M(-10.8%) | -$92.51 M(+7.3%) |
| June 2019 | - | -$25.67 M(+9.8%) | -$86.20 M(+4.1%) |
| Mar 2019 | - | -$23.38 M(+13.7%) | -$82.81 M(-2.3%) |
| Dec 2018 | -$84.72 M(-23.5%) | -$20.56 M(+23.9%) | -$84.72 M(-15.2%) |
| Sept 2018 | - | -$16.59 M(-25.6%) | -$99.92 M(-10.0%) |
| June 2018 | - | -$22.29 M(-11.9%) | -$110.97 M(-2.0%) |
| Mar 2018 | - | -$25.29 M(-29.3%) | -$113.27 M(+2.2%) |
| Dec 2017 | -$110.79 M(-678.5%) | -$35.75 M(+29.3%) | -$110.80 M(+64.9%) |
| Sept 2017 | - | -$27.64 M(+12.5%) | -$67.17 M(+1132.3%) |
| June 2017 | - | -$24.58 M(+7.7%) | -$5.45 M(-166.3%) |
| Mar 2017 | - | -$22.82 M(-389.9%) | $8.23 M(-57.0%) |
| Dec 2016 | $19.15 M(-151.4%) | $7.87 M(-76.9%) | $19.15 M(+725.8%) |
| Sept 2016 | - | $34.08 M(-412.5%) | $2.32 M(-105.7%) |
| June 2016 | - | -$10.90 M(-8.3%) | -$40.61 M(+0.8%) |
| Mar 2016 | - | -$11.89 M(+32.7%) | -$40.29 M(+8.0%) |
| Dec 2015 | -$37.23 M(+154.2%) | -$8.96 M(+1.3%) | -$37.31 M(+88.3%) |
| Sept 2015 | - | -$8.85 M(-16.4%) | -$19.82 M(+16.8%) |
| June 2015 | - | -$10.59 M(+18.9%) | -$16.97 M(+14.8%) |
| Mar 2015 | - | -$8.91 M(-204.5%) | -$14.79 M(+0.9%) |
| Dec 2014 | -$14.65 M(-56.6%) | $8.53 M(-242.2%) | -$14.65 M(-11.6%) |
| Sept 2014 | - | -$6.00 M(-28.7%) | -$16.57 M(-28.5%) |
| June 2014 | - | -$8.41 M(-4.1%) | -$23.18 M(-22.3%) |
| Mar 2014 | - | -$8.77 M(-232.7%) | -$29.84 M(-11.5%) |
| Dec 2013 | -$33.72 M | $6.61 M(-152.4%) | -$33.72 M(-34.9%) |
| Sept 2013 | - | -$12.61 M(-16.3%) | -$51.78 M(+5.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2013 | - | -$15.07 M(+19.1%) | -$49.21 M(+14.1%) |
| Mar 2013 | - | -$12.65 M(+10.4%) | -$43.12 M(+6.7%) |
| Dec 2012 | -$40.37 M(-15.6%) | -$11.46 M(+14.1%) | -$40.39 M(-1.0%) |
| Sept 2012 | - | -$10.04 M(+12.0%) | -$40.81 M(-1.4%) |
| June 2012 | - | -$8.97 M(-9.6%) | -$41.40 M(-10.1%) |
| Mar 2012 | - | -$9.93 M(-16.4%) | -$46.05 M(-3.7%) |
| Dec 2011 | -$47.82 M(-3.0%) | -$11.87 M(+11.7%) | -$47.82 M(+0.6%) |
| Sept 2011 | - | -$10.63 M(-21.9%) | -$47.54 M(-3.8%) |
| June 2011 | - | -$13.62 M(+16.4%) | -$49.41 M(+1.1%) |
| Mar 2011 | - | -$11.70 M(+0.9%) | -$48.88 M(-0.9%) |
| Dec 2010 | -$49.30 M(-296.4%) | -$11.59 M(-7.3%) | -$49.30 M(-1.4%) |
| Sept 2010 | - | -$12.50 M(-4.4%) | -$49.99 M(+9.7%) |
| June 2010 | - | -$13.08 M(+7.9%) | -$45.59 M(-293.4%) |
| Mar 2010 | - | -$12.12 M(-1.4%) | $23.57 M(-6.1%) |
| Dec 2009 | $25.10 M(-144.9%) | -$12.29 M(+51.8%) | $25.10 M(-6.9%) |
| Sept 2009 | - | -$8.10 M(-114.4%) | $26.95 M(+29.4%) |
| June 2009 | - | $56.07 M(-629.7%) | $20.83 M(-140.6%) |
| Mar 2009 | - | -$10.59 M(+1.4%) | -$51.28 M(-8.2%) |
| Dec 2008 | -$55.88 M(-1.1%) | -$10.44 M(-26.6%) | -$55.88 M(-7.5%) |
| Sept 2008 | - | -$14.22 M(-11.3%) | -$60.41 M(+1.7%) |
| June 2008 | - | -$16.04 M(+5.6%) | -$59.38 M(+2.5%) |
| Mar 2008 | - | -$15.19 M(+1.6%) | -$57.91 M(+2.5%) |
| Dec 2007 | -$56.49 M(-7.9%) | -$14.96 M(+13.3%) | -$56.49 M(-3.5%) |
| Sept 2007 | - | -$13.20 M(-9.4%) | -$58.51 M(-4.6%) |
| June 2007 | - | -$14.56 M(+5.8%) | -$61.31 M(-0.5%) |
| Mar 2007 | - | -$13.76 M(-18.9%) | -$61.63 M(+0.5%) |
| Dec 2006 | -$61.34 M(+37.4%) | -$16.98 M(+6.1%) | -$61.34 M(+9.4%) |
| Sept 2006 | - | -$16.00 M(+7.5%) | -$56.05 M(+10.4%) |
| June 2006 | - | -$14.89 M(+10.6%) | -$50.78 M(+8.1%) |
| Mar 2006 | - | -$13.47 M(+15.2%) | -$46.99 M(+5.3%) |
| Dec 2005 | -$44.63 M(+16.1%) | -$11.70 M(+9.0%) | -$44.63 M(-1.3%) |
| Sept 2005 | - | -$10.73 M(-3.4%) | -$45.23 M(+0.2%) |
| June 2005 | - | -$11.10 M(-0.1%) | -$45.15 M(+3.6%) |
| Mar 2005 | - | -$11.11 M(-9.6%) | -$43.57 M(+13.4%) |
| Dec 2004 | -$38.43 M(+17.9%) | -$12.29 M(+15.3%) | -$38.43 M(-42.3%) |
| Sept 2004 | - | -$10.65 M(+11.9%) | -$66.67 M(+24.9%) |
| June 2004 | - | -$9.52 M(+59.5%) | -$53.37 M(+9.9%) |
| Mar 2004 | - | -$5.97 M(-85.3%) | -$48.58 M(+2.0%) |
| Dec 2003 | -$32.59 M(+35.9%) | -$40.52 M(-1632.6%) | -$47.62 M(+571.1%) |
| Sept 2003 | - | $2.64 M(-155.9%) | -$7.09 M(-27.1%) |
| June 2003 | - | -$4.73 M(-5.5%) | -$9.74 M(+94.5%) |
| Mar 2003 | - | -$5.01 M | -$5.01 M |
| Dec 2002 | -$23.98 M(+30.4%) | - | - |
| Dec 2001 | -$18.39 M(+33.3%) | - | - |
| Dec 2000 | -$13.79 M | - | - |
FAQ
- What is Cytokinetics Incorporated annual earnings before interest & taxes?
- What is the all time high annual EBIT for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated annual EBIT year-on-year change?
- What is Cytokinetics Incorporated quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated quarterly EBIT year-on-year change?
- What is Cytokinetics Incorporated TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated TTM EBIT year-on-year change?
What is Cytokinetics Incorporated annual earnings before interest & taxes?
The current annual EBIT of CYTK is -$468.58 M
What is the all time high annual EBIT for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high annual earnings before interest & taxes is $27.12 M
What is Cytokinetics Incorporated annual EBIT year-on-year change?
Over the past year, CYTK annual earnings before interest & taxes has changed by -$130.78 M (-38.71%)
What is Cytokinetics Incorporated quarterly earnings before interest & taxes?
The current quarterly EBIT of CYTK is -$138.25 M
What is the all time high quarterly EBIT for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high quarterly earnings before interest & taxes is $56.07 M
What is Cytokinetics Incorporated quarterly EBIT year-on-year change?
Over the past year, CYTK quarterly earnings before interest & taxes has changed by -$22.82 M (-19.77%)
What is Cytokinetics Incorporated TTM earnings before interest & taxes?
The current TTM EBIT of CYTK is -$495.42 M
What is the all time high TTM EBIT for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high TTM earnings before interest & taxes is $26.95 M
What is Cytokinetics Incorporated TTM EBIT year-on-year change?
Over the past year, CYTK TTM earnings before interest & taxes has changed by -$25.57 M (-5.44%)